BACKGROUND/OBJECTIVES: to explore the effect of ageing on renal function with 
cystatin C as the marker of glomerular filtration rate (GFR) in the general 
population without vascular disease or diabetes.
DESIGN: a cross-sectional analysis of a healthy subset from the Good Aging in 
Skåne-cohort study representative of the Swedish general population.
SUBJECTS: 1252 participants without vascular disease and diabetes (43.9% men) of 
whom 203 were over 80 years old were included from the original cohort of 2931.
METHODS: plasma cystatin C and plasma creatinine were used as markers for GFR. 
Estimated GFR (eGFR) was calculated with three chronic kidney disease 
epidemiology collaboration (CKD-EPI) formulas involving cystatin C, creatinine 
or both.
RESULTS: the median for plasma cystatin C was 0.93 mg/l (60-69 years old), 1.04 
(70-79 years old) and 1.24 (80+ years old). The difference in mg/l between the 
5th and 95th percentile was 0.46, 0.62 and 0.90 for these age groups. Male sex 
increased the age effect on plasma cystatin C levels with 0.004 mg/l/year (P = 
0.03), adjusted for vascular risk factors. Smoking, lower HDL and higher 
diastolic blood pressure were associated with higher cystatin C levels. 54.7% 
(CKD-EPI creatinine) to 73.9% (CKD-EPI cystatin C) of the 80+ had an eGFR < 60 
ml/min/1.73 m2.
CONCLUSION: non-diabetics without overt vascular disease exhibit an age related 
but heterogeneous decline in renal function. The ageing effect is more 
pronounced in men. At least half of healthy 80+ years old could be expected to 
have at least CKD Stage 3 with eGFR < 60 ml/min/1.73 m2.